(redirected from Glucose Lowering Agent)
GLAGreater London Authority
GLAGamma Linolenic Acid
GLAGross Leasable Area
GLAGuide to Literary Agents (Writer's Digest book)
GLAGreater Los Angeles
GLAGlobal License Agreement
GLAGood Luck All
GLAGlobal Liberation Army (gaming)
GLAGay Lesbian Alliance (various locations)
GLAGross Living Area (real estate)
GLAGross Lettable Area
GLAGrenade Launcher (Australia)
GLAGreat Lakes Avengers (Marvel Comics)
GLAGroup Living Arrangement (various locations)
GLAGeorgia Library Association
GLAGeneric Log Adapter
GLAGaslight Anthem (New Brunswick, NJ band)
GLAGeneral Ledger Account
GLAGeneralized Lloyd Algorithm
GLAGraph Layout Algorithm
GLAGradual Learning Algorithm (linguistics)
GLAGoddard Laboratory for Atmospheres
GLAGreat Lakes Area
GLAGreat Lakes Aquarium
GLAGreatest Living American
GLAGreat Lakes Academy (private school; Plano, TX)
GLAGlasgow, Scotland, United Kingdom - Glasgow Scotland (Airport Code)
GLAGraduate Laboratory Assistant (various schools)
GLAGust Load Alleviation (aviation)
GLAGrand Larceny Auto
GLAGlucose Lowering Agent
GLAGhana Library Association (est. 1962)
GLAGlobal Label Allocation
GLAGaming Liberation Army (gaming)
References in periodicals archive ?
This communication is an evidence-based update to the 2012 South Asian Consensus guideline on the use of GLP-1 (glucagon-like peptide) analogue therapy in diabetes during Ramadan.1 It lists recently published data to support the rational use of GLP-1 receptor agonists (GLP1RA) as glucose lowering agents in Ramadan.
catechu can prove to be valuable glucose lowering agents in diabetic patients.
The researchers used data from GPs and identified 27,965 patients with type 2 diabetes whose treatment had been intensified to include two oral blood glucose lowering agents - metformin and sulphonylurea.
The mechanism of DPP-4 inhibitors is distinct from that of any currently available class of glucose lowering agents.
The degree of glucose control and use of insulin or other glucose lowering agents, nutritional status, body composition, heredity, medical abnormalities and current medical condition must be considered.
Goldstein noted that such patients are often taking several oral glucose lowering agents, most commonly metformin and a sulfonylurea in combination with a TZD, and that insulin is generally considered to be the next step.